Dec 2023 | ||
---|---|---|
Total Revenue | ||
Cost of Revenue | ||
Gross Profit | ||
Gross Profit Margin (%) | ||
R&D Expense | ||
SG&A Expense | ||
Total Operating Expenses | ||
Operating Income or Loss | ||
Operating Margin (%) | ||
Interest Expense | ||
Total Other Income/Expenses | ||
Income Before Tax | ||
Income Tax Expense | ||
Income from Continuing Ops. | ||
Net Income | ||
Net Profit Margin (%) | ||
Net Income Available to Common Shareholders | ||
Basic EPS | ||
Diluted EPS | ||
Basic Average Shares | ||
Diluted Average Shares |
Jun 2024 | Dec 2023 | ||
---|---|---|---|
Total Revenue | |||
Cost of Revenue | |||
Gross Profit | |||
Gross Profit Margin (%) | |||
R&D Expense | |||
SG&A Expense | |||
Total Operating Expenses | |||
Operating Income or Loss | |||
Operating Margin (%) | |||
Interest Expense | |||
Total Other Income/Expenses | |||
Income Before Tax | |||
Income Tax Expense | |||
Income from Continuing Ops. | |||
Net Income | |||
Net Profit Margin (%) | |||
Net Income Available to Common Shareholders | |||
Basic EPS | |||
Diluted EPS | |||
Basic Average Shares | |||
Diluted Average Shares |
Dec 2023 | ||
---|---|---|
Current Assets | ||
Cash & Cash Equivalents | ||
Marketable Securities | ||
Receivables | ||
Inventories | ||
Other Current Assets | ||
Total Current Assets | ||
Non-Current Assets | ||
Marketable Securities | ||
PPE Net | ||
Intangibles inc. Goodwill | ||
Other Non-Current Assets | ||
Total Non-Current Assets | ||
Total Assets | ||
Current Liabilities | ||
Accounts Payable | ||
Deferred Revenues | ||
Debt, Current | ||
Accrued Liabilities | ||
Other Current Liabilities | ||
Total Current Liabilities | ||
Non-Current Liabilities | ||
Deferred Revenues | ||
Debt, Non-Current | ||
Other Non-Current Liabilities | ||
Total Non-Current Liabilities | ||
Total Liabilities | ||
Shareholders' Equity | ||
Common Stock | ||
Additional Paid-In Capital | ||
Retained Earnings | ||
Other Shareholders' Equity | ||
Total Shareholders' Equity | ||
Total Liabilities & Shareholders' Equity |
Jun 2024 | Dec 2023 | ||
---|---|---|---|
Current Assets | |||
Cash & Cash Equivalents | |||
Marketable Securities | |||
Receivables | |||
Inventories | |||
Other Current Assets | |||
Total Current Assets | |||
Non-Current Assets | |||
Marketable Securities | |||
PPE Net | |||
Intangibles inc. Goodwill | |||
Other Non-Current Assets | |||
Total Non-Current Assets | |||
Total Assets | |||
Current Liabilities | |||
Accounts Payable | |||
Deferred Revenues | |||
Debt, Current | |||
Accrued Liabilities | |||
Other Current Liabilities | |||
Total Current Liabilities | |||
Non-Current Liabilities | |||
Deferred Revenues | |||
Debt, Non-Current | |||
Other Non-Current Liabilities | |||
Total Non-Current Liabilities | |||
Total Liabilities | |||
Shareholders' Equity | |||
Common Stock | |||
Additional Paid-In Capital | |||
Retained Earnings | |||
Other Shareholders' Equity | |||
Total Shareholders' Equity | |||
Total Liabilities & Shareholders' Equity |
Dec 2023 | ||
---|---|---|
Cash Flows from Operating Activities | ||
Net Income | ||
Depreciation & Amortization | ||
Deferred Income Taxes | ||
Stock Based Compensation | ||
Accounts Receivable | ||
Inventory | ||
Accounts Payable | ||
Deferred Revenue | ||
Other Non-Cash | ||
Operating Cash Flow | ||
Cash Flows from Investing Activities | ||
PPE Investments | ||
Net Acquisitions | ||
Purchase of Investments | ||
Sale of Investments | ||
Other Investing Activity | ||
Investing Cash Flow | ||
Cash Flows from Financing Activities | ||
Debt Issued | ||
Proceeds from Debt Repayment | ||
Debt Repayment | ||
Proceeds from Sale of Equity | ||
Equity Repurchased | ||
Dividend Paid | ||
Other Financing Activity | ||
Financing Cash Flow | ||
Cash Position | ||
Beginning Cash Position | ||
End Cash Position | ||
Change in Cash | ||
Free Cash Flow | ||
Operating Cash Flow | ||
Capital Expenditure | ||
Free Cash Flow |
Jun 2024 | Dec 2023 | ||
---|---|---|---|
Cash Flows from Operating Activities | |||
Net Income | |||
Depreciation & Amortization | |||
Deferred Income Taxes | |||
Stock Based Compensation | |||
Accounts Receivable | |||
Inventory | |||
Accounts Payable | |||
Deferred Revenue | |||
Other Non-Cash | |||
Operating Cash Flow | |||
Cash Flows from Investing Activities | |||
PPE Investments | |||
Net Acquisitions | |||
Purchase of Investments | |||
Sale of Investments | |||
Other Investing Activity | |||
Investing Cash Flow | |||
Cash Flows from Financing Activities | |||
Debt Issued | |||
Proceeds from Debt Repayment | |||
Debt Repayment | |||
Proceeds from Sale of Equity | |||
Equity Repurchased | |||
Dividend Paid | |||
Other Financing Activity | |||
Financing Cash Flow | |||
Cash Position | |||
Beginning Cash Position | |||
End Cash Position | |||
Change in Cash | |||
Free Cash Flow | |||
Operating Cash Flow | |||
Capital Expenditure | |||
Free Cash Flow |